Intravenous Infusion Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Description
Fairfield Market Research has recently released a detailed report on the global Intravenous Infusion Pumps Market, presenting an in-depth evaluation of the industry’s key dynamics, including growth drivers, restraints, opportunities, and emerging trends. The study provides stakeholders with valuable insights into the evolving market landscape, enabling strategic and informed decision-making.
Market Insights
The global intravenous infusion pumps market is projected to be valued at US$ 7.1 Bn in 2025 and is expected to reach US$ 13.6 Bn by 2032, expanding at a CAGR of 9.73% between 2025 and 2032. Rising incidences of chronic and lifestyle-related diseases, combined with increasing hospitalization and long-term care needs, are fueling the demand for infusion pumps. The adoption of advanced and smart infusion systems, coupled with the growing role of home healthcare, is further reinforcing the growth trajectory of the industry.
Intravenous Infusion Pumps Market – Report Scope
The intravenous infusion pumps market includes a broad range of medical devices designed to deliver controlled doses of medications, nutrients, and fluids directly into the bloodstream. These devices are integral to modern medical practice, with applications across oncology, pain management, pediatrics, hematology, and critical care. With the increasing need for precision drug delivery and the development of smart technologies featuring wireless connectivity and safety monitoring systems, the market is poised for significant advancements. The rising preference for compact, portable infusion systems in home healthcare settings also underscores the expanding scope of this market.
Market Growth Drivers
The market is experiencing robust growth driven by several key factors. The rising prevalence of chronic conditions such as diabetes, cancer, and cardiovascular diseases has led to an increased need for infusion-based therapies. Growing awareness regarding the importance of accurate and safe drug delivery systems is also fueling demand. Furthermore, technological innovations like dose-error reduction software, remote monitoring, and wireless connectivity are enhancing patient outcomes, pushing hospitals and clinics toward higher adoption. An aging global population, which requires frequent and long-term medical care, further amplifies market growth.
Market Restraints
High acquisition and maintenance costs of advanced infusion pumps remain a key barrier in cost-sensitive healthcare systems. Frequent product recalls due to safety concerns or mechanical failures can negatively impact brand reputation and adoption. Additionally, limited awareness and inadequate training for medical staff in emerging markets restrict the widespread utilization of these devices. Regulatory complexities and lengthy approval processes for new technologies pose further challenges for manufacturers. Collectively, these factors are likely to slow down adoption in certain regions despite growing overall demand.
Market Opportunities
The intravenous infusion pumps industry is expected to benefit significantly from expanding home healthcare services and the rising acceptance of portable infusion devices. Emerging economies in Asia-Pacific and Latin America present strong growth opportunities as healthcare infrastructure modernizes and access to advanced treatments improves. Increasing investment in digital healthcare and IoT-enabled smart pumps will further open avenues for innovation and competitive differentiation. Moreover, growing demand for personalized medicine and targeted drug delivery is encouraging the development of specialized infusion technologies tailored to individual patient needs.
Regional Outlook
North America is anticipated to lead the intravenous infusion pumps market, supported by a mature healthcare infrastructure, higher spending on medical technologies, and the strong presence of leading manufacturers. Europe is expected to follow closely, driven by rising geriatric populations and supportive healthcare policies. Asia-Pacific is likely to register the fastest growth during the forecast period, fueled by increasing investments in hospital infrastructure, higher chronic disease prevalence, and government-backed healthcare initiatives. Latin America and the Middle East & Africa are projected to show steady progress as healthcare access improves across these regions.
Leading Companies
Prominent players are focusing on advancing technology, enhancing product safety, and expanding global reach through strategic partnerships and acquisitions. These companies continue to invest in product innovations, including wireless, portable, and error-reduction-enabled infusion pumps, to strengthen their competitive positioning.
Companies Covered in This Report:
• Baxter International
• B. Braun Melsungen AG
• Medtronic
• Micrel Medical Devices SA
• Boston Scientific Corporation
• BD
• Fresenius Kabi
• Smiths Medical
• F. Hoffmann-La Roche Ltd.
• Mindray
Market Segmentation
By Product Type
• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Patient-Controlled Analgesia (PCA) Infusion Pumps
• Others
By Application
• Pediatrics/Neonatology
• Chemotherapy
• Pain Management
• Hematology
• Others
By End-user
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Market Insights
The global intravenous infusion pumps market is projected to be valued at US$ 7.1 Bn in 2025 and is expected to reach US$ 13.6 Bn by 2032, expanding at a CAGR of 9.73% between 2025 and 2032. Rising incidences of chronic and lifestyle-related diseases, combined with increasing hospitalization and long-term care needs, are fueling the demand for infusion pumps. The adoption of advanced and smart infusion systems, coupled with the growing role of home healthcare, is further reinforcing the growth trajectory of the industry.
Intravenous Infusion Pumps Market – Report Scope
The intravenous infusion pumps market includes a broad range of medical devices designed to deliver controlled doses of medications, nutrients, and fluids directly into the bloodstream. These devices are integral to modern medical practice, with applications across oncology, pain management, pediatrics, hematology, and critical care. With the increasing need for precision drug delivery and the development of smart technologies featuring wireless connectivity and safety monitoring systems, the market is poised for significant advancements. The rising preference for compact, portable infusion systems in home healthcare settings also underscores the expanding scope of this market.
Market Growth Drivers
The market is experiencing robust growth driven by several key factors. The rising prevalence of chronic conditions such as diabetes, cancer, and cardiovascular diseases has led to an increased need for infusion-based therapies. Growing awareness regarding the importance of accurate and safe drug delivery systems is also fueling demand. Furthermore, technological innovations like dose-error reduction software, remote monitoring, and wireless connectivity are enhancing patient outcomes, pushing hospitals and clinics toward higher adoption. An aging global population, which requires frequent and long-term medical care, further amplifies market growth.
Market Restraints
High acquisition and maintenance costs of advanced infusion pumps remain a key barrier in cost-sensitive healthcare systems. Frequent product recalls due to safety concerns or mechanical failures can negatively impact brand reputation and adoption. Additionally, limited awareness and inadequate training for medical staff in emerging markets restrict the widespread utilization of these devices. Regulatory complexities and lengthy approval processes for new technologies pose further challenges for manufacturers. Collectively, these factors are likely to slow down adoption in certain regions despite growing overall demand.
Market Opportunities
The intravenous infusion pumps industry is expected to benefit significantly from expanding home healthcare services and the rising acceptance of portable infusion devices. Emerging economies in Asia-Pacific and Latin America present strong growth opportunities as healthcare infrastructure modernizes and access to advanced treatments improves. Increasing investment in digital healthcare and IoT-enabled smart pumps will further open avenues for innovation and competitive differentiation. Moreover, growing demand for personalized medicine and targeted drug delivery is encouraging the development of specialized infusion technologies tailored to individual patient needs.
Regional Outlook
North America is anticipated to lead the intravenous infusion pumps market, supported by a mature healthcare infrastructure, higher spending on medical technologies, and the strong presence of leading manufacturers. Europe is expected to follow closely, driven by rising geriatric populations and supportive healthcare policies. Asia-Pacific is likely to register the fastest growth during the forecast period, fueled by increasing investments in hospital infrastructure, higher chronic disease prevalence, and government-backed healthcare initiatives. Latin America and the Middle East & Africa are projected to show steady progress as healthcare access improves across these regions.
Leading Companies
Prominent players are focusing on advancing technology, enhancing product safety, and expanding global reach through strategic partnerships and acquisitions. These companies continue to invest in product innovations, including wireless, portable, and error-reduction-enabled infusion pumps, to strengthen their competitive positioning.
Companies Covered in This Report:
• Baxter International
• B. Braun Melsungen AG
• Medtronic
• Micrel Medical Devices SA
• Boston Scientific Corporation
• BD
• Fresenius Kabi
• Smiths Medical
• F. Hoffmann-La Roche Ltd.
• Mindray
Market Segmentation
By Product Type
• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Patient-Controlled Analgesia (PCA) Infusion Pumps
• Others
By Application
• Pediatrics/Neonatology
• Chemotherapy
• Pain Management
• Hematology
• Others
By End-user
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Please note: Delivery Timelines - 5 working days.
Table of Contents
202 Pages
- 1. Executive Summary
- 1.1. Global Infectious Disease In-vitro Diagnostics Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2025
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global Infectious Disease In-vitro Diagnostics Market Outlook, 2019-2032
- 3.1. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
- 3.1.1. Key Highlights
- 3.1.1.1. Instruments
- 3.1.1.2. Reagents
- 3.1.1.3. Services
- 3.2. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2019-2032
- 3.2.1. Key Highlights
- 3.2.1.1. Immunoassay
- 3.2.1.2. Molecular Diagnostics
- 3.2.1.3. Microbiology
- 3.2.1.4. Other Technologies
- 3.3. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
- 3.3.1. Key Highlights
- 3.3.1.1. MRSA
- 3.3.1.2. Streptococcus
- 3.3.1.3. Clostridium Difficile
- 3.3.1.4. Respiratory Virus
- 3.3.1.5. TB and Drug-resistant TB
- 3.3.1.6. Gonorrhea
- 3.3.1.7. HPV
- 3.3.1.8. HIV
- 3.3.1.9. Hepatitis C
- 3.3.1.10. Hepatitis B
- 3.3.1.11. COVID-19
- 3.3.1.12. Other Applications
- 3.4. Global Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
- 3.4.1. Key Highlights
- 3.4.1.1. Point of care
- 3.4.1.2. Central Laboratories
- 3.4.1.3. Other End-uses
- 3.5. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Region, Value (US$ Bn), 2019-2032
- 3.5.1. Key Highlights
- 3.5.1.1. North America
- 3.5.1.2. Europe
- 3.5.1.3. Asia Pacific
- 3.5.1.4. Latin America
- 3.5.1.5. Middle East & Africa
- 4. North America Infectious Disease In-vitro Diagnostics Market Outlook, 2019-2032
- 4.1. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
- 4.1.1. Key Highlights
- 4.1.1.1. Instruments
- 4.1.1.2. Reagents
- 4.1.1.3. Services
- 4.2. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2019-2032
- 4.2.1. Key Highlights
- 4.2.1.1. Immunoassay
- 4.2.1.2. Molecular Diagnostics
- 4.2.1.3. Microbiology
- 4.2.1.4. Other Technologies
- 4.3. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
- 4.3.1. Key Highlights
- 4.3.1.1. MRSA
- 4.3.1.2. Streptococcus
- 4.3.1.3. Clostridium Difficile
- 4.3.1.4. Respiratory Virus
- 4.3.1.5. TB and Drug-resistant TB
- 4.3.1.6. Gonorrhea
- 4.3.1.7. HPV
- 4.3.1.8. HIV
- 4.3.1.9. Hepatitis C
- 4.3.1.10. Hepatitis B
- 4.3.1.11. COVID-19
- 4.3.1.12. Other Applications
- 4.4. North America Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
- 4.4.1. Key Highlights
- 4.4.1.1. Point of care
- 4.4.1.2. Central Laboratories
- 4.4.1.3. Other End-uses
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
- 4.5. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 4.5.1. Key Highlights
- 4.5.1.1. U.S. Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 4.5.1.2. U.S. Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 4.5.1.3. U.S. Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 4.5.1.4. U.S. Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 4.5.1.5. Canada Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 4.5.1.6. Canada Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 4.5.1.7. Canada Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 4.5.1.8. Canada Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 4.5.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe Infectious Disease In-vitro Diagnostics Market Outlook, 2019-2032
- 5.1. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
- 5.1.1. Key Highlights
- 5.1.1.1. Instruments
- 5.1.1.2. Reagents
- 5.1.1.3. Services
- 5.2. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2019-2032
- 5.2.1. Key Highlights
- 5.2.1.1. Immunoassay
- 5.2.1.2. Molecular Diagnostics
- 5.2.1.3. Microbiology
- 5.2.1.4. Other Technologies
- 5.3. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
- 5.3.1. Key Highlights
- 5.3.1.1. MRSA
- 5.3.1.2. Streptococcus
- 5.3.1.3. Clostridium Difficile
- 5.3.1.4. Respiratory Virus
- 5.3.1.5. TB and Drug-resistant TB
- 5.3.1.6. Gonorrhea
- 5.3.1.7. HPV
- 5.3.1.8. HIV
- 5.3.1.9. Hepatitis C
- 5.3.1.10. Hepatitis B
- 5.3.1.11. COVID-19
- 5.3.1.12. Other Applications
- 5.4. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
- 5.4.1. Key Highlights
- 5.4.1.1. Point of care
- 5.4.1.2. Central Laboratories
- 5.4.1.3. Other End-uses
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
- 5.5. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 5.5.1. Key Highlights
- 5.5.1.1. Germany Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.2. Germany Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.3. Germany Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.4. Germany Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.1.5. U.K. Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.6. U.K. Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.7. U.K. Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.8. U.K. Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.1.9. France Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.10. France Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.11. France Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.12. France Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.1.13. Italy Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.14. Italy Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.15. Italy Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.16. Italy Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.1.17. Turkey Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.18. Turkey Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.19. Turkey Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.20. Turkey Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.1.21. Russia Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.22. Russia Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.23. Russia Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.24. Russia Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.1.25. Rest of Europe Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 5.5.1.26. Rest of Europe Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 5.5.1.27. Rest of Europe Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 5.5.1.28. Rest of Europe Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 5.5.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, 2019-2032
- 6.1. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
- 6.1.1. Key Highlights
- 6.1.1.1. Instruments
- 6.1.1.2. Reagents
- 6.1.1.3. Services
- 6.2. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2019-2032
- 6.2.1. Key Highlights
- 6.2.1.1. Immunoassay
- 6.2.1.2. Molecular Diagnostics
- 6.2.1.3. Microbiology
- 6.2.1.4. Other Technologies
- 6.3. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
- 6.3.1. Key Highlights
- 6.3.1.1. MRSA
- 6.3.1.2. Streptococcus
- 6.3.1.3. Clostridium Difficile
- 6.3.1.4. Respiratory Virus
- 6.3.1.5. TB and Drug-resistant TB
- 6.3.1.6. Gonorrhea
- 6.3.1.7. HPV
- 6.3.1.8. HIV
- 6.3.1.9. Hepatitis C
- 6.3.1.10. Hepatitis B
- 6.3.1.11. COVID-19
- 6.3.1.12. Other Applications
- 6.4. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
- 6.4.1. Key Highlights
- 6.4.1.1. Point of care
- 6.4.1.2. Central Laboratories
- 6.4.1.3. Other End-uses
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
- 6.5. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 6.5.1. Key Highlights
- 6.5.1.1. China Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 6.5.1.2. China Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 6.5.1.3. China Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 6.5.1.4. China Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 6.5.1.5. Japan Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 6.5.1.6. Japan Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 6.5.1.7. Japan Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 6.5.1.8. Japan Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 6.5.1.9. South Korea Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 6.5.1.10. South Korea Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 6.5.1.11. South Korea Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 6.5.1.12. South Korea Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 6.5.1.13. India Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 6.5.1.14. India Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 6.5.1.15. India Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 6.5.1.16. India Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 6.5.1.17. Southeast Asia Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 6.5.1.18. Southeast Asia Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 6.5.1.19. Southeast Asia Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 6.5.1.20. Southeast Asia Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 6.5.1.21. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 6.5.1.22. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 6.5.1.23. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 6.5.1.24. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, 2019-2032
- 7.1. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
- 7.1.1. Key Highlights
- 7.1.1.1. Instruments
- 7.1.1.2. Reagents
- 7.1.1.3. Services
- 7.2. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2019-2032
- 7.2.1.1. Immunoassay
- 7.2.1.2. Molecular Diagnostics
- 7.2.1.3. Microbiology
- 7.2.1.4. Other Technologies
- 7.3. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
- 7.3.1. Key Highlights
- 7.3.1.1. MRSA
- 7.3.1.2. Streptococcus
- 7.3.1.3. Clostridium Difficile
- 7.3.1.4. Respiratory Virus
- 7.3.1.5. TB and Drug-resistant TB
- 7.3.1.6. Gonorrhea
- 7.3.1.7. HPV
- 7.3.1.8. HIV
- 7.3.1.9. Hepatitis C
- 7.3.1.10. Hepatitis B
- 7.3.1.11. COVID-19
- 7.3.1.12. Other Applications
- 7.4. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
- 7.4.1. Key Highlights
- 7.4.1.1. Point of care
- 7.4.1.2. Central Laboratories
- 7.4.1.3. Other End-uses
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
- 7.5. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 7.5.1. Key Highlights
- 7.5.1.1. Brazil Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 7.5.1.2. Brazil Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 7.5.1.3. Brazil Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 7.5.1.4. Brazil Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 7.5.1.5. Mexico Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 7.5.1.6. Mexico Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 7.5.1.7. Mexico Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 7.5.1.8. Mexico Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 7.5.1.9. Argentina Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 7.5.1.10. Argentina Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 7.5.1.11. Argentina Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 7.5.1.12. Argentina Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 7.5.1.13. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 7.5.1.14. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 7.5.1.15. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 7.5.1.16. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, 2019-2032
- 8.1. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
- 8.1.1. Key Highlights
- 8.1.1.1. Instruments
- 8.1.1.2. Reagents
- 8.1.1.3. Services
- 8.2. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2019-2032
- 8.2.1. Key Highlights
- 8.2.1.1. Immunoassay
- 8.2.1.2. Molecular Diagnostics
- 8.2.1.3. Microbiology
- 8.2.1.4. Other Technologies
- 8.3. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
- 8.3.1. Key Highlights
- 8.3.1.1. MRSA
- 8.3.1.2. Streptococcus
- 8.3.1.3. Clostridium Difficile
- 8.3.1.4. Respiratory Virus
- 8.3.1.5. TB and Drug-resistant TB
- 8.3.1.6. Gonorrhea
- 8.3.1.7. HPV
- 8.3.1.8. HIV
- 8.3.1.9. Hepatitis C
- 8.3.1.10. Hepatitis B
- 8.3.1.11. COVID-19
- 8.3.1.12. Other Applications
- 8.4. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
- 8.4.1. Key Highlights
- 8.4.1.1. Point of care
- 8.4.1.2. Central Laboratories
- 8.4.1.3. Other End-uses
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
- 8.5. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
- 8.5.1. Key Highlights
- 8.5.1.1. GCC Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 8.5.1.2. GCC Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 8.5.1.3. GCC Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 8.5.1.4. GCC Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 8.5.1.5. South Africa Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 8.5.1.6. South Africa Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 8.5.1.7. South Africa Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 8.5.1.8. South Africa Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 8.5.1.9. Egypt Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 8.5.1.10. Egypt Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 8.5.1.11. Egypt Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 8.5.1.12. Egypt Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 8.5.1.13. Nigeria Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 8.5.1.14. Nigeria Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 8.5.1.15. Nigeria Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 8.5.1.16. Nigeria Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 8.5.1.17. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2019-2032
- 8.5.1.18. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2019-2032
- 8.5.1.19. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2019-2032
- 8.5.1.20. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2019-2032
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. Product vs Application Heatmap
- 9.2. Manufacturer vs Indication Heatmap
- 9.3. Company Market Share Analysis, 2024
- 9.4. Competitive Dashboard
- 9.5. Company Profiles
- 9.5.1. Abbott Laboratories
- 9.5.1.1. Company Overview
- 9.5.1.2. Product Portfolio
- 9.5.1.3. Financial Overview
- 9.5.1.4. Business Strategies and Development
- 9.5.2. Thermo Fisher Scientific Inc.
- 9.5.2.1. Company Overview
- 9.5.2.2. Product Portfolio
- 9.5.2.3. Financial Overview
- 9.5.2.4. Business Strategies and Development
- 9.5.3. F. Hoffmann-La Roche Ltd.
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Portfolio
- 9.5.3.3. Financial Overview
- 9.5.3.4. Business Strategies and Development
- 9.5.4. bioMérieux SA
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Portfolio
- 9.5.4.3. Financial Overview
- 9.5.4.4. Business Strategies and Development
- 9.5.5. Siemens Healthineers AG
- 9.5.5.1. Company Overview
- 9.5.5.2. Product Portfolio
- 9.5.5.3. Financial Overview
- 9.5.5.4. Business Strategies and Development
- 9.5.6. Danaher Corporation
- 9.5.6.1. Company Overview
- 9.5.6.2. Product Portfolio
- 9.5.6.3. Financial Overview
- 9.5.6.4. Business Strategies and Development
- 9.5.7. Becton Dickinson and Company
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Portfolio
- 9.5.7.3. Financial Overview
- 9.5.7.4. Business Strategies and Development
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.